Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Dec;47(12):3724-32.
doi: 10.1128/AAC.47.12.3724-3732.2003.

Prevalence and molecular epidemiology of CTX-M extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals

Affiliations

Prevalence and molecular epidemiology of CTX-M extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals

M Edelstein et al. Antimicrob Agents Chemother. 2003 Dec.

Abstract

A total of 904 consecutive nosocomial isolates of Escherichia coli and Klebsiella pneumoniae collected from 28 Russian hospitals were screened for production of extended-spectrum beta-lactamases (ESBLs). The ESBL phenotype was detected in 78 (15.8%) E. coli and 248 (60.8%) K. pneumoniae isolates. One hundred fifteen isolates carried the genes for CTX-M-type beta-lactamases, which, as shown by PCR-restriction fragment length polymorphism analysis, were distributed into the two genetic groups of CTX-M-1 (93%)- and CTX-M-2 (7%)-related enzymes. Isolates producing the enzymes of the first group were found in 20 hospitals from geographically distant regions of the country and were characterized by considerable diversity of genetic types, as was demonstrated by enterobacterial repetitive consensus PCR typing. Within this group the CTX-M-3 and the CTX-M-15 beta-lactamases were identified. In contrast, the enzymes of the CTX-M-2 group (namely, CTX-M-5) were detected only in eight clonally related E. coli isolates from a single hospital. Notably, the levels of resistance to ceftazidime were remarkably variable among the CTX-M producers. This study provides further evidence of the global dissemination of CTX-M type ESBLs and emphasizes the need for their epidemiological monitoring.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Geographiclocations of hospitals surveyed in this study.
FIG. 2.
FIG. 2.
Detection and differentiation of blaCTX-M genes by PCR-RFLP. Lanes 1 to 5, undigested PCR products; lanes 6 to 10, PstI-PvuII-digested PCR products; lanes 1 and 6, C. freundii 2525 (CTX-M-3); lanes 2 and 7, S. enterica serovar Typhimurium CAS5 (CTX-M-2); lanes 3 and 8, K. ascorbata T861 (KluA); lanes 4 and 9, E. coli (CTX-M-9); lanes 5 and 10, E. coli C600 (TEM-1); lanes M, molecular size marker (pUC18-HaeIII).
FIG. 3.
FIG. 3.
Unweighted pair-group method using arithmetic averages clustering of ERIC-PCR profiles of CTX-M-producing strains. The isolates representing major clonal outbreaks are outlined.

References

    1. Baraniak, A., J. Fiett, A. Sulikowska, W. Hryniewicz, and M. Gniadkowski. 2002. Countrywide spread of CTX-M-3 extended-spectrum β-lactamase-producing microorganisms of the family Enterobacteriaceae in Poland. Antimicrob. Agents Chemother. 46:151-159. - PMC - PubMed
    1. Baraniak, A., J. Fiett, W. Hryniewicz, P. Nordmann, and M. Gniadkowski. 2002. Ceftazidime-hydrolysing CTX-M-15 extended-spectrum β-lactamase (ESBL) in Poland. J. Antimicrob. Chemother. 50:393-396. - PubMed
    1. Bauernfeind, A., H. Grimm, and S. Schweighart. 1990. A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. Infection 18:294-298. - PubMed
    1. Bauernfeind, A., I. Stemplinger, R. Jungwirth, S. Ernst, and J. M. Casellas. 1996. Sequences of β-lactamase genes encoding CTX-M-1 (MEN-1) and CTX-M-2 and relationship of their amino acid sequences with those of other β-lactamases. Antimicrob. Agents Chemother. 40:509-513. - PMC - PubMed
    1. Bauernfeind, A., J. M. Casellas, and M. Goldberg. 1992. A new plasmidic cefotaximase from patients infected with Salmonella typhimurium. Infection 20:158-163. - PubMed

MeSH terms

Substances